Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Long-term Ibrutinib for Lymphoma
Recruiting2 awardsPhase 3
Columbus, Ohio
This trial will provide long-term safety and efficacy data for people taking ibrutinib, as well as continuing access to the drug for people who have benefited from it in the past.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.